Search

Your search keyword '"Tsukune, Yutaka"' showing total 6 results
Start Over Author "Tsukune, Yutaka" Database Supplemental Index
6 results on '"Tsukune, Yutaka"'

3. A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Author

Saito, Akio, Isoda, Atsushi, Odajima, Takeshi, Itagaki, Mitsuhiro, Yamamoto, Go, Hagiwara, Shotaro, Ohno, Tatsuharu, Fujimoto, Ayumi, Sekiguchi, Naohiro, Sunami, Kazutaka, Yokohama, Akihiko, Kurokawa, Mineo, Tsukune, Yutaka, Nakazawa, Hideyuki, Takamatsu, Hiroyuki, Yagi, Hideo, Fuchida, Shin-Ichi, Ito, Shigeki, Harazaki, Yoriko, Watanabe, Reiko, Koike, Michiaki, Miyazaki, Kanji, Suzuki, Kazuhito, Tamura, Hideto, Kohara, Takae, Ozaki, Shuji, Nakamura, Nobuhiko, Nakamura, Yuichi, Wakayama, Toshio, Sugimori, Hiroki, and Murakami, Hirokazu

Abstract

Yamamoto: Bristol-Myers Squibb: Honoraria. Hagiwara:Celgene: Membership on an entity's Board of Directors or advisory committees; Bristol Myers Squibb: Membership on an entity's Board of Directors or advisory committees. Sunami:Celgene: Honoraria, Research Funding; Sanofi: Research Funding; Janssen: Research Funding; Daiichi-Sankyo: Research Funding; Ono: Honoraria, Research Funding; Bristol-Myers Squibb K.K.: Honoraria, Research Funding; AbbVie: Research Funding; Takeda: Research Funding; MSD: Research Funding; GlaxoSmithKline: Research Funding; Novartis: Research Funding. Kurokawa:Teijin Pharma: Research Funding; Eizai: Research Funding; Kyowa Hakko Kirin: Honoraria, Research Funding; Chugai Pharmaceutical: Research Funding; Sumitomo Dainippon Pharma: Research Funding; Pfizer: Research Funding; Takeda Pharmaceutical: Research Funding; MSD: Honoraria, Research Funding; Ono Pharmaceutical: Honoraria, Research Funding; Nippon Sinyaku: Honoraria, Research Funding; Astellas Pharma: Research Funding; Otsuka Pharmaceutical: Research Funding. Takamatsu:Janssen: Honoraria; Celgene: Honoraria, Research Funding; Bristol-Myers Squibb: Research Funding; Ono: Research Funding. Ito:Bristol-Myers Squibb, Celgene: Honoraria. Tamura:Bristol-Myers Squibb: Honoraria; Celgene: Honoraria, Research Funding; Ono Pharmaceutical: Honoraria; Takeda Pharmaceutical: Honoraria.

Published
2018
Full Text
View/download PDF

4. A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Author

Saito, Akio, Isoda, Atsushi, Odajima, Takeshi, Itagaki, Mitsuhiro, Yamamoto, Go, Hagiwara, Shotaro, Ohno, Tatsuharu, Fujimoto, Ayumi, Sekiguchi, Naohiro, Sunami, Kazutaka, Yokohama, Akihiko, Kurokawa, Mineo, Tsukune, Yutaka, Nakazawa, Hideyuki, Takamatsu, Hiroyuki, Yagi, Hideo, Fuchida, Shin-Ichi, Ito, Shigeki, Harazaki, Yoriko, Watanabe, Reiko, Koike, Michiaki, Miyazaki, Kanji, Suzuki, Kazuhito, Tamura, Hideto, Kohara, Takae, Ozaki, Shuji, Nakamura, Nobuhiko, Nakamura, Yuichi, Wakayama, Toshio, Sugimori, Hiroki, and Murakami, Hirokazu

Abstract

Background:We recently reported that the International Prognostic Scoring System for Waldenström macroglobulinemia (ISSWM), which is widely used to predict the prognosis of WM patients, might not be applicable to Japanese patients, and evidence of pleural effusion might be a novel adverse prognostic factor for symptomatic WM in the rituximab era. Further studies with a large number of patients are deemed to be conducted.

Published
2018
Full Text
View/download PDF

5. Retrospective Analysis of Prognostic Factors for Waldenström Macroglobulinemia: A Multicenter Cooperative Study in Japan

Author

Saito, Akio, Isoda, Atsushi, Yokohama, Akihiko, Handa, Hiroshi, Tsukamoto, Norifumi, Tsukune, Yutaka, Sasaki, Makoto, Matsumoto, Morio, Sawamura, Morio, Ito, Shigeki, Toyama, Kohtaro, Koike, Michiaki, Murayama, Kayoko, Onodera, Asaka, Moriya, Keiichi, Tamura, Hideto, Nakahashi, Hirotaka, Tanosaki, Sakae, Sakura, Toru, Karasawa, Masamitsu, Iwashina, Masanori, Kojima, Masaru, Nakamura, Naoya, and Murakami, Hirokazu

Abstract

No relevant conflicts of interest to declare.

Published
2015
Full Text
View/download PDF

6. Retrospective Analysis of Prognostic Factors for Waldenström Macroglobulinemia: A Multicenter Cooperative Study in Japan

Author

Saito, Akio, Isoda, Atsushi, Yokohama, Akihiko, Handa, Hiroshi, Tsukamoto, Norifumi, Tsukune, Yutaka, Sasaki, Makoto, Matsumoto, Morio, Sawamura, Morio, Ito, Shigeki, Toyama, Kohtaro, Koike, Michiaki, Murayama, Kayoko, Onodera, Asaka, Moriya, Keiichi, Tamura, Hideto, Nakahashi, Hirotaka, Tanosaki, Sakae, Sakura, Toru, Karasawa, Masamitsu, Iwashina, Masanori, Kojima, Masaru, Nakamura, Naoya, and Murakami, Hirokazu

Abstract

Background:Analysis of prognostic factors and clinical trials of novel agents for Waldenstrӧm macroglobulinemia (WM) are ongoing in Western countries, but few studies of WM have been performed in Japan. As a step toward future investigations, we retrospectively analyzed clinical features and prognostic factors in Japanese patients with WM.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results